AASLD Webinars are online educational sessions that bring together a wide range of professionals to discuss the latest controversies and issues in the various sub-specialty fields of hepatology. Through these short, innovative sessions, participants can ask the experts questions about hot topics within their respective fields. Webinars are held throughout the year, with some presentations posted to LiverLearning®.
| 2023 Webinars Optimizing the Liver Clinic’s Role in Managing Alcohol Use Disorder (AUD) Among Patients with Alcohol-Associated Liver Disease (ALD) Presented by the Alcohol-associated Liver Disease Special Interest Group Immune Tolerance in Chronic Hepatitis B: Mechanisms, Management, and Controversies Presented by the Hepatitis B Special Interest Group 2022 Webinars Management of Autoimmune Hepatitis Not Achieving Remission Presented by the Clinical Practice Special Interest Group A New Worldwide Enigma: Increased Reporting of Cases of Acute Hepatitis in Children Jointly Presented by the North American Society for Pediatric Gastroenterology (NASPGHAN) and AASLD Using Mass Cytometry to Decipher Mechanisms of Liver Diseases Presented by the Liver Cell Biology in Hepatic Diseases SIG The Art and Science of Managing Acute on Chronic Liver Failure Presented by the Acute on Chronic Liver Failure Special Interest Group Endovascular vs Endoscopic Management of Gastric Varices: Which is Better? Presented by the Portal Hypertension Clinical and Experimental Special Interest Group Covid in Focus: Outpatient Therapeutics and Managing Liver Transplant Donors and Recipients Presented by the AASLD COVID-19 Task Force's Clinical Oversight and Education Subcommittee Applications of TIPS for Portal Hypertension: Entering a New Era (Now Available) Presented by the Portal Hypertension Special Interest Group Going Beyond the Statement: Improving Diversity, Equity and Inclusion in Hepatology Presented by the Inclusion and Diversity Committee Getting the Most Out of the Mentor-Mentee Relationship Presented by the Membership and Mentorship Committee HBV DNA Integration: Mechanisms, Pathogenesis and Clinical Relevance in Liver Disease Progression and Functional Cure Presented by the Hepatitis B Special Interest Group |
2021 Webinars PSC and Hepatic Fibrosis: An Update from the Field Presented by the Liver Fibrosis Special Interest Group AASLD's Thought Leaders Series: How I Manage My Practice Presented by the AASLD President Microbiome in NASH and Cirrhosis Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group Promoting Equity, Diversity and Inclusion in Communication Near the End of Life Presented by the Membership and Mentorship and Inclusion and Diversity Committees NASH Congressional Briefing Presented by AASLD and the Global Liver Institute How Can Patients Get Involved with The Liver Meeting Presented by the Public Policy Committee Biliary Atresia: Where Are We and Where Do We Go From Here? Presented by the Pediatric Liver Disorders Special Interest Group The Use of Quantitative HBsAg in Clinical Practice Presented by the Hepatitis B Special Interest Group Cardiovascular Disease in NASH Patients Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group Genetics of NAFLD Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group Gaps in Advance Care Planning at Transplant Centers: Call for Action Presented by the Public Health/Healthcare Delivery Special Interest Group NASH as a Cause of Hepatocellular Carcinoma Presented by the Non-alcoholic Fatty Liver Disease Special Interest Group Natural History of NAFLD/NASH in Children: Knowledge, Gaps and Interventions Presented by the Pediatric Liver Disorders Special Interest Group Challenges in NASH Clinical Trials Presented by the Non-alcoholic Fatty Liver Disease Special Interest Group Acute on Chronic Liver Failure (ACLF) in Alcohol-associated Liver Disease (ALD) Presented by the Acute on Chronic Liver Failure and Alcohol-associated Liver Disease Special Interest Groups FY21 Peer Reviewed Cancer Research Program Funding Opportunities in Liver Cancer Presented by the Public Policy Committee Simultaneous Liver Kidney Transplant: How Did We Do With the New Criteria? Presented by the Liver Transplantation and Surgery Special Interest Group Use of Serum and Imaging Biomarkers of NAFLD/NASH in Clinical Practice Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group Developing a Career in Clinical Research Presented by the Hepatitis B Special Interest Group To Stop or Not to Stop: The Practice of Finite Nucleos(T)ide Analog Therapy Presented by the Hepatitis B Special Interest Group Practical Approach to Coagulation Management in Cirrhosis Presented by the Clinical Practice Special Interest Group |
2020 Webinars New E/M Requirements are Coming January 1: Will You be Ready? Presented by the Public Policy Committee Chronic Hepatitis C 500: The Advanced Course Presented by the Hepatitis C Special Interest Group Treatment Strategies for Autoimmune Hepatitis Beyond First-line Therapy Presented by the Cholestatic and Autoimmune Liver Diseases Special Interest Group Novel Models for HCV Care Delivery Presented by the Hepatitis C Special Interest Group Current and Future Disease Burden of HBV: Global and Regional Perspectives (Live Q&A Panel Discussion) Presented by the Hepatitis B Special Interest Group Global Public Health Strategies for the Prevention of ALD in 2020 Presented by the Alcohol-associated Liver Disease Special Interest Group Dietary Recommendations for NAFLD Patients: What Do I Tell My Patients? Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group Hepatitis C: Infection Beyond the Liver Presented by the Hepatitis C Special Interest Group Chronic Hepatitis C 101: The Basics Presented by the Hepatitis C Special Interest Group Prevention and Management of Ascites in Cirrhosis: Controversies and New Approaches Presented by the Portal Hypertension Special Interest Group Implementation Science of Patient Reported Outcomes (PROs) Presented by the Public Health/Healthcare Delivery Special Interest Group NLRB - How Is It Working So Far? Presented by the Liver Transplantation journal Are You Digitally Secure? Presented by the Communications and Technology Committee |
2019 Webinars Cannabis and The Liver: Update for the Hepatologist Presented by the Clinical Practice Special Interest Group Integrated Management of Alcohol-Related Liver Disease with Hepatologists and Addiction Specialists Presented by the Alcohol-Related Liver Disease Special Interest Group The Diverse Presentation and Diagnosis of Liver Injury Due to Drugs or Herbal and Dietary Supplements Presented by the Hepatotoxicity Special Interest Group Systematic Screening for NAFLD-Related Advanced Fibrosis in Patient with Type 2 Diabetes, Where Do We Stand? Presented by the Non-alcoholic Fatty Liver Disease Special Interest Group Liquid Biopsy in Hepatocellular Carcinoma: Applications in Surveillance and Prediction of Treatment Response Presented by the Hepatobiliary Neoplasia Special Interest Group Overview of Transplantation for Acute on Chronic Liver Failure Presented by the Acute on Chronic Liver Failure Special Interest Group New Insights into the Pathogenesis and Management of Cystic Fibrosis-Related Liver Disease Presented by the Pediatric Liver Disorders Special Interest Group HCC Staging and Treatments Presented by the Hepatology Associates Special Interest Group Palliative Care: What It Is and When To Use It Presented by the Public Health/Health Care Delivery Special Interest Group HBV Reactivation: How to Approach the Immunosuppressed Patient Presented by the Hepatitis B Special Interest Group The 2018 Primary Biliary Cholangitis Practice Guidance: Highlights Presented by the Cholestatic and Autoimmune Liver Diseases Special Interest Group Early Liver Transplantation in Alcoholic Hepatitis Presented by the Alcoholic Liver Disease Special Interest Group Challenges in Antiviral Therapy for Hepatitis C Presented by the Hepatitis C Special Interest Group Evaluation of Renal Dysfunction and Hyponatremia in Patients with Cirrhosis Presented by the Clinical Practice Special Interest Group HCV Treatment in Patients with IDU Presented by the Hepatitis C Special Interest Group Management of NAFLD: Integrating Strategies from Obesity Medicine into Clinical Practice Presented by the Nonalcoholic Fatty Liver Disease Special Interest Group Liver Lesions 101 Presented by the Hepatology Associates Special Interest Group |
2018 Webinars Best Practices for Managing Cardiovascular Risk After Liver Transplantation Presented by the Cardiopulmonary Affinity Group HBV - Update on the Guidelines and Controversies in Management Presented by the Hepatitis B Special Interest Group Cardiac Risk in Liver Transplantation: Getting to the “Heart” of the Matter Presented by the Cardiopulmonary Affinity Group Implications of the Hepatitis C Epidemic on Women & Children Presented by the Hepatitis C Special Interest Group Unraveling the New UNOS Liver Allocation Policy Presented by the Liver Transplantation and Surgery SIG & Liver Transplantation Journal Role of Diet and Exercise in the Management of NAFLD Presented by the Non-Alcoholic Fatty Liver Disease Special Interest Group Cost-Effective Approach to Evaluation of Abnormal Liver Enzymes Presented by the Clinical Practice Special Interest Group Acute on Chronic Liver Failure in Children Presented by the Pediatric Liver Disorders Special Interest Group Surgical Risk in the Portal Hypertensive Patient Presented by the Portal Hypertension Special Interest Group |
2017 Webinars Portal Vein Thrombosis in Cirrhosis: Causes and Consequences Presented by the Portal Hypertension Special Interest Group Controversy Regarding HCV Treatment and HCC Recurrence Presented by the Hepatobiliary Neoplasia Special Interest Group Frailty the “Sixth Vital Sign” in Cirrhosis - How Do We Diagnose It and What Can We Do When We Find It? Presented by the Acute on Chronic Liver Failure Special Interest Group Fibrosis Regression: Mechanisms and Clinical Consequences Presented by the Liver Fibrosis Special Interest Group Chronic Hepatitis B and Pregnancy: Management and Prevention of Vertical Transmission Presented by the Hepatitis B Special Interest Group Surrogate Endpoints in Primary Sclerosing Cholangitis (PSC) Presented by the Cholestatic and Biliary Diseases Special Interest Group New DAA's and Controversies in HCV: What Clinicians Need to Know Presented by the Hepatitis C Special Interest Group |
| Access Date | Quiz Result | Score | Actions |
|---|
